Perelman School of Medicine

One tiny dog’s outsized contribution to brain surgery

A terrier mix makes history as the first patient to undergo canine neurosurgery in a collaborative effort of specialists in human and veterinary medicine using cutting-edge augmented reality technology and infrared imaging.

Person with stethoscope using a smartphone.

Text message tool addresses ‘time toxicity’ for cancer patients

In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.

A smiling woman stands facing the camera with her arms crossed. She is standing in front of a glass-fronted row of offices with a glass railing in front of her. She is wearing a white coat and maroon head covering.

Who, What, Why

Who, What, Why: Medical student Bayan Galal aims to tackle global health challenges

The first-year Penn Medicine student and graduate associate at Perry World House draws her inspiration from her family’s lived experience.

New mRNA therapy could repair damaged lungs

Penn researchers have designed an organ-specific mRNA and lipid nanoparticle therapy which could lead to new targeted treatments for damaged organs.

Person receiving treatment in a dental clinic.

Getting to the root of root canals

Penn researchers use iron oxide nanozymes to treat infections during root canals with fewer adverse effects than clinical gold standard while also promoting tissue healing.

illustration of translucent human lower abdomen with illuminated kidneys.

Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus

Researchers suggest changes in kidney transplant care and monitoring.

An infusion bag hanging in a hospital room.

With hemophilia B, a lifetime of worry eased with one infusion

The first Penn Medicine patient to receive an FDA-approved new gene therapy for hemophilia B can now stop regular prophylactic clotting factor injections.

Four portraits arranged in a 2x2 grid. Clockwise from top left: Jason Altschuler, Cesar de la Fuente, Liang Wu, and Anderson Ye Zhang

Four from Penn named 2025 Sloan Research Fellows

Jason Altschuler, César de la Fuente, Liang Wu, and Anderson Ye Zhang have been honored as early-career researchers and scholars for their accomplishments, creativity, and potential to become leaders in their fields.

A researcher holding a vaccine vial in a lab next to a microscope.

Pursuing vaccines to stop celiac disease

Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.

Researchers create genetic map tied to kidney disease

The creation of the most complete map of more than 1,000 genes that influence kidney function could help experts diagnose and design targeted treatments for kidney disease.

Filters